InsiderClue
Insiders · Profile

Dougherty Donald

SVP & Chief Financial Officer at Rein Therapeutics. Filing since 1 Jun 2018. CIK 0001709592

Company
Date
Role
Action
Shares
Amount
Of holding
RNTX Rein Therapeutics, Inc.
8 Jun 2018
SVP & Chief Financial Officer
Bought
3,000
$16.20K
150%
RNTX Rein Therapeutics, Inc.
1 Jun 2018
SVP & Chief Financial Officer
Bought
2,000
$10.48K
opened
2 decisions on file.